119 related articles for article (PubMed ID: 8246579)
1. Cardiopulmonary bypass significantly reduces surfactant activity in children.
McGowan FX; Ikegami M; del Nido PJ; Motoyama EK; Kurland G; Davis PJ; Siewers RD
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):968-77. PubMed ID: 8246579
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of ambroxol on pulmonary function after cardiopulmonary bypass.
Ulas MM; Hizarci M; Kunt A; Ergun K; Kocabeyoglu SS; Korkmaz K; Lafci G; Gedik S; Cagli K
J Cardiovasc Pharmacol; 2008 Dec; 52(6):518-23. PubMed ID: 19034033
[TBL] [Abstract][Full Text] [Related]
3. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary bypass reduces pulmonary surfactant activity in infants.
Griese M; Wilnhammer C; Jansen S; Rinker C
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):237-44. PubMed ID: 10424996
[TBL] [Abstract][Full Text] [Related]
5. Compositional and functional changes of pulmonary surfactant in a guinea-pig model of chronic asthma.
Cheng G; Ueda T; Sugiyama K; Toda M; Fukuda T
Respir Med; 2001 Mar; 95(3):180-6. PubMed ID: 11266234
[TBL] [Abstract][Full Text] [Related]
6. Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children.
Friedrich B; Schmidt R; Reiss I; Günther A; Seeger W; Müller M; Thul J; Schranz D; Gortner L
Crit Care Med; 2003 Jan; 31(1):284-90. PubMed ID: 12545030
[TBL] [Abstract][Full Text] [Related]
7. Total liquid ventilation reduces lung injury in piglets after cardiopulmonary bypass.
Jiang L; Wang Q; Liu Y; Du M; Shen X; Guo X; Wu S
Ann Thorac Surg; 2006 Jul; 82(1):124-30. PubMed ID: 16798202
[TBL] [Abstract][Full Text] [Related]
8. [The effects of cardiopulmonary bypass on pulmonary surfactant activity].
Xing Q; Zhang S; Chen Z
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):225-7. PubMed ID: 10072808
[TBL] [Abstract][Full Text] [Related]
9. Effects of Stachybotrys chartarum on surfactant convertase activity in juvenile mice.
Mason CD; Rand TG; Oulton M; MacDonald J; Anthes M
Toxicol Appl Pharmacol; 2001 Apr; 172(1):21-8. PubMed ID: 11264019
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary injury after cardiopulmonary bypass: beneficial effects of low-frequency mechanical ventilation.
Imura H; Caputo M; Lim K; Ochi M; Suleiman MS; Shimizu K; Angelini GD
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1530-7. PubMed ID: 19464476
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome.
Schmidt R; Markart P; Ruppert C; Temmesfeld B; Nass R; Lohmeyer J; Seeger W; Günther A
Crit Care Med; 2006 Sep; 34(9):2370-6. PubMed ID: 16849999
[TBL] [Abstract][Full Text] [Related]
13. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
[TBL] [Abstract][Full Text] [Related]
14. Surfactant pretreatment ameliorates ischemia-reperfusion injury of the lung.
van der Kaaij NP; Haitsma JJ; Kluin J; Lambrecht BN; Lachmann B; de Bruin RW; Bogers AJ
Eur J Cardiothorac Surg; 2005 May; 27(5):774-82. PubMed ID: 15848313
[TBL] [Abstract][Full Text] [Related]
15. Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot.
Wei B; Liu Y; Wang Q; Yu C; Long C; Chang Y; Ruan Y
Ann Thorac Surg; 2004 Mar; 77(3):918-24. PubMed ID: 14992899
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhaled corticosteroid on pulmonary injury and inflammatory mediator production after cardiopulmonary bypass in children.
Santos AR; Heidemann SM; Walters HL; Delius RE
Pediatr Crit Care Med; 2007 Sep; 8(5):465-9. PubMed ID: 17693905
[TBL] [Abstract][Full Text] [Related]
17. Effects of exogenous surfactant instillation in clinical lung transplantation: a prospective, randomized trial.
Strüber M; Fischer S; Niedermeyer J; Warnecke G; Gohrbandt B; Görler A; Simon AR; Haverich A; Hohlfeld JM
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1620-5. PubMed ID: 17532965
[TBL] [Abstract][Full Text] [Related]
18. Ischemic and endotoxin pre-conditioning reduce lung reperfusion injury-induced surfactant alterations.
Markart P; Schmidt R; Ruppert C; Höres C; Silber RE; Börgermann J; Günther A; Friedrich I
J Heart Lung Transplant; 2005 Oct; 24(10):1680-9. PubMed ID: 16210147
[TBL] [Abstract][Full Text] [Related]
19. Glutathione replacement preserves the functional surfactant phospholipid pool size and decreases sepsis-mediated lung dysfunction in ethanol-fed rats.
Velasquez A; Bechara RI; Lewis JF; Malloy J; McCaig L; Brown LA; Guidot DM
Alcohol Clin Exp Res; 2002 Aug; 26(8):1245-51. PubMed ID: 12198401
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary surfactant composition early in development of acute lung injury after cardiopulmonary bypass: prophylactic use of surfactant therapy.
Haslam PL; Baker CS; Hughes DA; MacNaughton PD; Moat NE; Dewar A; Aggarwal A; Evans TW
Int J Exp Pathol; 1997 Aug; 78(4):277-89. PubMed ID: 9505939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
